nerves innervating the panniculus carnosus were microsugically dissected free and transected distally to allow transposition onto the ipsilateral decellularized matrix implant. Neurotization was performed on both the deep and superficial surfaces of the matrix with 3-5 nerves total implanted based on anatomic feasibility. Rats were sacrificed and tissue harvest was carried out on post-operative days 90 and 180. Tissue samples were assessed through gross appearance, immunohistochemistry, and western blot analysis for myogenesis, inflammation, neovascularity, and neural ingrowth within the explanted matrices and defects alone.
PURPOSE:
With an aging population, degenerative diseases such as osteoarthritis are expected to increase. Hyaline cartilage has a poor propensity to regenerate. To ameliorate its healing capacity patients are being offered multiple "stem cell" therapies with little or no evidence behind their claims. With a unique insight into the Skeletal Stem Cell we aim to share new insights into our manipulation of the SSC through surgical, biochemical and cellular treatments.
METHODS:
Skeletally mature mice were used throughout. An N=10 was used for each group unless stated. Clonality was assessed using Actin and Sox9 Cre-ER Rainbow mouse models induced with tamoxifen. Cell number was assessed with FACS using previously published FACS gating profiles. Proliferation was assessed using EdU assays by IHC and intracellular FACS. Cellular origin was assessed with our parabiosis model. Differentiation capacity was assessed in vitro and in vivo (both subcapsular and orthotopic). Biochemical manipulation used hydrogel and collagen scaffolds. Cellular treatments used labelled cell population transplantation orthotopically.
RESULTS:
Following surgical manipulation, clonality was confirmed within the regenerate. A significant increase (p<0.05) in the number of SSC was seen at 1 and 2 weeks post operatively. The regenerate contained proliferating cells. There was a significant increase (p<0.05) in SSC proliferation following surgery. The significant increase in SSC within the area was due to a local increase of SSC. The fate of those SSC is affected by our temporal biochemical factors following injury. Addition of prospective FACS isolated cellular subpopulations augments the native SSC population.
CONCLUSIONS:
Our approach to manipulating SSC fate towards hyaline cartilage regeneration is a novel, cell-specific, targeted therapy. We now aim to translate this research into the clinical setting and optimize our protocol for regenerating hyaline cartilage. 
METHODS:
10 mm excisional dorsal wounds were created in wild-type (WT), diabetic (db/db), conventional nrf2 knockout (Nrf2 -/-), K14-CreER-flox (epithelial specific, inducible), and Cdh5-CreER-flox (endothelial specific, inducible) mice. Wounds were analyzed grossly and histologically for time to closure (days until healing), wound burden (excisional wound area), epithelial gap (marker of re-epithelialization), and granulation tissue formation. Additionally, wound tissue was obtained from non-diabetic and diabetic patients and analyzed for histology, immunoreactivity of fluorescent stains (Nrf2, K14, CD31), oxidative stress (8-OhdG, a marker of reactive oxygen species (ROS) end-products), and expression of Nrf2-downstream anti-oxidant enzymes (western blot).
RESULTS:
In mice, time to wound closure was delayed in Nrf2-/-beyond WT (19d vs. 17d), but not as long as K14-CreER-flox or Cdh5-CreER-flox mice (30d), whose phenotype more closely resembled that of db/db (32d). Pathological wound burden was significantly increased in db/db, K14-CreER-flox, and Cdh5-CreER-flox mice as compared to Nrf2-/-and db/db, p<0.0001. Histologic wound analysis revealed that epithelial gap in both K14-CreER-flox (day 7: 8.7mm, day 10: 6.03mm) and 6 .889) mice more closely resembled db/db (10.07mm, 7.55mm), than WT (6.088mm, 4.346) or Nrf2-/-(5.89mm, 5.558mm), p<0.0003. Granulation tissue was with significantly decreased formation in db/ db (.4561mm2), K14CreER-flox (1.083mm2), and Cdh5-CreER-flox (1.873mm2) as compared to WT (4.827mm2) and Nrf2 -/-(2.98mm2) mice, p<0.02. In CD31+ cells within human diabetic wounds, Nrf2 expression was decreased 55% compared to non-diabetic wounds (1.6x10 -6 vs. 1.9x10
-6 corrected total cell fluorescence (CTCF)). Nrf2 expression was slightly decreased in wound-edge keratin-14+ keratinocytes in human diabetic wounds as compared to non-diabetic wounds (7. 2 ) in human diabetic wounds as compared to non-diabetic wounds. Despite more oxidative stress within diabetic wounds as compared to non-diabetic wounds (4.941 ng/mL vs 1.572 ng/mL, p=0.008), expression of Nrf2-downstream anti-oxidant enzyme MnSOD increased 10-fold in nondiabetic wounds, while only a 3-fold increase was seen in diabetic wounds (p<0.001).
